135 related articles for article (PubMed ID: 38178749)
1. [SRF-rearranged cellular perivascular myoid tumor: a clinicopathological analysis of two cases].
Yin TC; Shao MY; Sun M; Zhao L; Lao QY; Yao QL; Bai QM; Yu L; Zhou XY; Wang J
Zhonghua Bing Li Xue Za Zhi; 2024 Jan; 53(1):64-70. PubMed ID: 38178749
[No Abstract] [Full Text] [Related]
2. SRF Fusions Other Than With RELA Expand the Molecular Definition of SRF-fused Perivascular Tumors.
Karanian M; Kelsey A; Paindavoine S; Duc A; Vanacker H; Hook L; Weinbreck N; Delfour C; Minard V; Baillard P; Blay JY; Pissaloux D; Tirode F
Am J Surg Pathol; 2020 Dec; 44(12):1725-1735. PubMed ID: 33021523
[TBL] [Abstract][Full Text] [Related]
3. Recurrent SRF-RELA Fusions Define a Novel Subset of Cellular Myofibroma/Myopericytoma: A Potential Diagnostic Pitfall With Sarcomas With Myogenic Differentiation.
Antonescu CR; Sung YS; Zhang L; Agaram NP; Fletcher CD
Am J Surg Pathol; 2017 May; 41(5):677-684. PubMed ID: 28248815
[TBL] [Abstract][Full Text] [Related]
4. Novel SRF-ICA1L Fusions in Cellular Myoid Neoplasms With Potential For Malignant Behavior.
Suurmeijer AJ; Dickson BC; Swanson D; Sung YS; Zhang L; Antonescu CR
Am J Surg Pathol; 2020 Jan; 44(1):55-60. PubMed ID: 31478943
[TBL] [Abstract][Full Text] [Related]
5. Expanding the Spectrum of Perioral Myogenic Tumors in Pediatric Patients: An
Slack JC; Hollowell ML; Khouri KS; Church AJ; Ganske IM; Delano S; Al-Ibraheemi A
Pediatr Dev Pathol; 2023; 26(1):65-71. PubMed ID: 36457254
[TBL] [Abstract][Full Text] [Related]
6. Myopericytoma of skin and soft tissues: clinicopathologic and immunohistochemical study of 54 cases.
Mentzel T; Dei Tos AP; Sapi Z; Kutzner H
Am J Surg Pathol; 2006 Jan; 30(1):104-13. PubMed ID: 16330949
[TBL] [Abstract][Full Text] [Related]
7. Cellular myofibromas with SRF fusions: clinicopathological and molecular study of 3 cases of a rare entity and a potential mimic of sarcoma.
Papa B; Nguyen MA; Kumar A; Song L; Dorwal P; Cheah AL
Hum Pathol; 2023 Aug; 138():41-48. PubMed ID: 37245628
[TBL] [Abstract][Full Text] [Related]
8. [Clinicopathological study of BCOR rearrangement in high grade endometrial stromal sarcoma].
Cheng YF; Bai QM; Bi R; Chang B; Huang D; Yu L; Zhou XY; Yang WT; Tu XY
Zhonghua Bing Li Xue Za Zhi; 2019 Aug; 48(8):604-609. PubMed ID: 31422590
[No Abstract] [Full Text] [Related]
9. [Clinicopathologic and molecular genetic characterizations of biphenotypic sinonasal sarcoma].
Zhao M; Weng LaoI; Zhao DH; Ma J; Ru GQ; He XL; Wang Z; Wang J
Zhonghua Bing Li Xue Za Zhi; 2017 Dec; 46(12):841-846. PubMed ID: 29224278
[No Abstract] [Full Text] [Related]
10. CD34-positive infantile myofibromatosis: Case report and review of hemangiopericytoma-like pattern tumors.
Kiyohara T; Maruta N; Iino S; Ido H; Tokuriki A; Hasegawa M
J Dermatol; 2016 Sep; 43(9):1088-91. PubMed ID: 27074874
[TBL] [Abstract][Full Text] [Related]
11. [Mammary myofibroblastoma: a clinicopathologic analysis of nine cases].
Yu BH; Bai QM; Xu XL; Yang WT; Wang J
Zhonghua Bing Li Xue Za Zhi; 2018 Oct; 47(10):747-752. PubMed ID: 30317728
[No Abstract] [Full Text] [Related]
12. [Angiofibroma of soft tissue: a clinicopathologic analysis of 24 cases].
Xu XL; Liu JG; Sun M; Yu L; Liu QY; Bai QM; Wu LJ; Wang J
Zhonghua Bing Li Xue Za Zhi; 2018 Aug; 47(8):616-621. PubMed ID: 30107667
[No Abstract] [Full Text] [Related]
13. [Clinicopathologic features and immunophenotype of pseudosarcomatous myofibroblastic proliferation of urinary bladder].
Zhang YH; Zhang XR; Yu J; Li HL
Zhonghua Bing Li Xue Za Zhi; 2018 Aug; 47(8):585-590. PubMed ID: 30107662
[No Abstract] [Full Text] [Related]
14. Uterine tumours with myogenic differentiation harbouring SRF::RELA fusions.
Li Y; Huang D; Bi R; Yao Q; Ge L; Yu L; Zhou X; Yang W
Histopathology; 2022 Oct; 81(4):477-485. PubMed ID: 35852178
[TBL] [Abstract][Full Text] [Related]
15. [CIC-rearranged sarcoma:a clinicopathological analysis of 10 cases].
Zhao L; Sun M; Weng QY; Yu L; Wang J
Zhonghua Bing Li Xue Za Zhi; 2019 Jul; 48(7):515-521. PubMed ID: 31288305
[No Abstract] [Full Text] [Related]
16. [EWSR1-SMAD3 positive fibroblastic tumor: a clinicopathological analysis].
Su HY; Zhao L; Ji G; Yao QL; Bai QM; Zhou XY; Wang J
Zhonghua Bing Li Xue Za Zhi; 2023 Jan; 52(1):19-24. PubMed ID: 36617901
[No Abstract] [Full Text] [Related]
17. Phenotypic characterization of perivascular myoid cell neoplasms, using myosin 1B, a newly identified human pericyte marker.
Meguro S; Akamatsu T; Matsushima S; Kosugi I; Kawasaki H; Arai Y; Baba S; Tsuchida T; Shido Y; Suda T; Iwashita T
Hum Pathol; 2017 Apr; 62():187-198. PubMed ID: 28088345
[TBL] [Abstract][Full Text] [Related]
18. [Myofibroma/myofibromatosis: a clinicopathologic analysis of 9 cases].
Fu Y; Guan WY; Wu HY; Wu HY; Fan ZW; Ye Q; Meng FQ
Zhonghua Bing Li Xue Za Zhi; 2018 Jan; 47(1):45-50. PubMed ID: 29325250
[No Abstract] [Full Text] [Related]
19. Myofibromatosis in adults, glomangiopericytoma, and myopericytoma: a spectrum of tumors showing perivascular myoid differentiation.
Granter SR; Badizadegan K; Fletcher CD
Am J Surg Pathol; 1998 May; 22(5):513-25. PubMed ID: 9591720
[TBL] [Abstract][Full Text] [Related]
20. [Perivascular epithelioid cell tumor of the lung: a clinicopathological analysis of eight cases].
Li J; Huang RP; Pang P; Guo X; Wang YH; Guo LC; Huang S
Zhonghua Bing Li Xue Za Zhi; 2023 Nov; 52(11):1126-1131. PubMed ID: 37899318
[No Abstract] [Full Text] [Related]
[Next] [New Search]
